Therefore, P-selectin blockade is not only envisaged as a promising anti-inflammatory strategy but also represents a potential approach to suppress angiogenesis and metastasis by inhibiting endothelial cell migration and disrupting the formation of tumor cell-platelet emboli complexes. Here, SELP is linked to neoplasm.